Hubert L. Allen

2020

In 2020, Hubert L. Allen earned a total compensation of $8.5M as Executive Vice President, General Counsel and Secretary at Abbott Laboratories, a 13% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$2,904,940
Non-Equity Incentive Plan$917,700
Option Awards$1,874,988
Salary$751,346
Stock Awards$1,874,607
Other$154,596
Total$8,478,177

Allen received $2.9M of change in pension value and nonqualified deferred compensation earnings, accounting for 34% of the total pay in 2020.

Allen also received $917.7K in non-equity incentive plan, $1.9M in option awards, $751.3K in salary, $1.9M in stock awards and $154.6K in other compensation.

Rankings

In 2020, Hubert L. Allen's compensation ranked 1,072nd out of 13,090 executives tracked by ExecPay. In other words, Allen earned more than 91.8% of executives.

ClassificationRankingPercentile
All
1,072
out of 13,090
92nd
Division
Manufacturing
375
out of 5,617
93rd
Major group
Chemicals And Allied Products
130
out of 2,248
94th
Industry group
Drugs
114
out of 1,948
94th
Industry
Pharmaceutical Preparations
84
out of 1,453
94th

Pay ratio

Hubert L. Allen's Pay$8,478,177
Median Employee's Pay$77,594
Pay Ratio

109

to 1

In 2020, the annual total compensation of Hubert L. Allen was $8,478,177.

The annual total compensation of the median employee at Abbott Laboratories was $77,594.

The ratio of Hubert L. Allen's pay to the pay of median employee was therefore 109 to one.

Source: SEC filing on March 12, 2021.

Allen's colleagues

We found six more compensation records of executives who worked with Hubert L. Allen at Abbott Laboratories in 2020.

2020

Robert Ford

Abbott Laboratories

Chief Executive Officer

2020

Miles White

Abbott Laboratories

Chairman

2020

Robert Funck

Abbott Laboratories

Chief Financial Officer

2020

John Ginascol

Abbott Laboratories

Executive Vice President, Core Diagnostics

2020

Daniel Salvadori

Abbott Laboratories

Executive Vice President, Nutritional Products

2020

Brian Yoor

Abbott Laboratories

Chief Financial Officer

News

You may also like